Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
ICICI Pru Nifty Alpha Low - Volatility 30 ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.5.421050753990.3876
Domestic EquitiesBharti Airtel Ltd.5.349354814989.1921
Domestic EquitiesICICI Bank Ltd.4.887062674681.4832
Domestic EquitiesLupin Ltd.4.363935480372.7612
Domestic EquitiesITC Ltd.4.1523145220769.2340
Domestic EquitiesBajaj Auto Ltd.3.71496856761.9410
Domestic EquitiesUltratech Cement Ltd.3.58655338259.7993
Domestic EquitiesLarsen & Toubro Ltd.3.565715961359.4527
Domestic EquitiesColgate - Palmolive (India) Ltd.3.391919570856.5547
Domestic EquitiesBritannia Industries Ltd.3.391811445356.5529
Domestic EquitiesReliance Industries Ltd.3.383843661156.4189
Domestic EquitiesDr. Reddy's Laboratories Ltd.3.349446449555.8462
Domestic EquitiesNTPC Ltd.3.3490153550755.8387
Domestic EquitiesSiemens Ltd.3.33917363455.6736
Domestic EquitiesMaruti Suzuki India Ltd.3.31734994555.3101
Domestic EquitiesGrasim Industries Ltd.3.223920624653.7529
Domestic EquitiesTVS Motor Company Ltd.3.173921737852.9196
Domestic EquitiesNestle India Ltd.3.099923129451.6861
Domestic EquitiesState Bank Of India3.099661602751.6816
Domestic EquitiesTitan Company Ltd.3.073415772451.2445
Domestic EquitiesICICI Lombard General Insurance Company Ltd.2.994726818949.9328
Domestic EquitiesCummins India Ltd.2.925113999748.7708
Domestic EquitiesTorrent Pharmaceuticals Ltd.2.675413419044.6074
Domestic EquitiesAxis Bank Ltd.2.657738998044.3134
Domestic EquitiesBosch Ltd.2.63401256043.9175
Domestic EquitiesTata Motors Ltd.2.549354047742.5058
Domestic EquitiesTata Consumer Products Ltd.2.538644153342.3276
Domestic EquitiesOil & Natural Gas Corporation Ltd.2.3983155776439.9878
Domestic EquitiesMRF Ltd.2.2453298937.4376
Domestic EquitiesZydus Lifesciences Ltd.2.140136940835.6830
Total 99.9921 1667.2146
Cash & Cash Equivalents and Net AssetsTREPS0.2101 3.5029
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.2022 -3.3715
Total 0.0079 0.1314
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.